Narrative review / 2013
Calcium supplements were found to increase the risk of myocardial infarction and stroke, with risks appearing to outweigh skeletal benefits.
This review evaluates the cardiovascular safety and skeletal efficacy of calcium supplements. While calcium supplements slow bone loss, meta-analyses show only a 10% decrease in fractures. A recent meta-analysis of randomized, placebo-controlled trials found calcium supplements increased the risk of myocardial infarction by 27%-31% and stroke by 12%-20%, adverse effects not lessened by co-administration of vitamin D. The authors conclude that the non-skeletal risks appear to outweigh any skeletal benefits.
- Study type
- Narrative review with discussion of meta-analyses
- Who was studied
- Normal older women, patients with renal impairment, and general populations
- What was measured
- Myocardial infarction, stroke, cardiovascular disease, bone loss, and fractures
THE PAPER
Cardiovascular effects of calcium supplements.
Reid IR. Nutrients, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.